Antibodies specific to glycoprotein (gp) of ebolavirus and uses for the treatment and diagnosis of ebola virus infection

The present invention relates to antibodies or fragments thereof that specifically bind to glycoprotein (GP) of Ebola virus, and to their use for treating and diagnosing Ebola virus disease.

Keywords: neutralizing monoclonal antibody

Patent Application number: United States Of America (PSP) - 09 Févr. 2015 - 62/113,597

Inventors:

VOLCHKOV Viktor

Publications:

J Infect Dis. 2015 Oct 1;212 Suppl 2:S372-8. doi: 10.1093/infdis/jiv303. Epub 2015 Aug 1.

Reference:

BIO14444-T1

Inserm Transfert
Business Developer

Phone

E-mail

Patent filling date: 06-03-2015

Rare disease: No

Second indication: No

Antibodies specific to glycoprotein (gp) of ebolavirus and uses for the treatment and diagnosis of ebola virus infection

You might also be interested in